Skip to content
Evidilya, People & Research First®
Submit an RFP
During · IP & study supplies

IP & study supplies management.

Investigational product and study supplies, governed by Evidilya, executed via qualified GDP depot and courier partners. Labelling, release, IRT, distribution, reconciliation and returns run on a single audit trail, the same trail as the clinical data.

People & Research First®
What we do

The work, made concrete.

Not a service brochure, the actual scope, the actual deliverables, and how it plugs into ECS®.

  • Governance & GMP documentation
    Label design and approval, IB alignment, protocol-specific handling instructions, blinding oversight and QP release liaison, under Evidilya quality management.
  • IRT / RTSM on ECS®
    Randomisation, drug-supply forecasting, resupply triggers and unblinding workflows, configured on ECS®, integrated with capture and monitoring.
  • Distribution via qualified GDP partners
    EU and regional depots, cold-chain and ambient logistics, customs and import licences, executed by GDP-qualified partners under continuous Evidilya oversight.
  • Direct-to-Participant delivery
    Home delivery under investigator supervision, chain-of-custody, temperature and receipt captured inside the same participant record.
  • Reconciliation, returns & destruction
    Accountability logs, unused-product returns and certified destruction, inspection-ready evidence, assembled as the study runs.
People behind the work

Every deliverable has a name on it.

Every engagement is led by named specialists who own the outcome. You get the same faces from kick-off to close-out.
Participant receiving investigational product at home under investigator supervision
Deliverables

What you receive.

Every engagement lands with named artefacts you can use.

  • IP management plan (governance, roles, GMP handling)
  • IRT / RTSM specification and validated build on ECS®
  • Qualified GDP depot network, activated and audited
  • Chain-of-custody and temperature-excursion log across every touchpoint
  • Reconciliation reports and destruction certificates
How it fits ECS®

IP events, shipment, receipt, temperature, dispensing, return, flow into the same ECS® audit trail as clinical data. One record per participant, one trail for the inspector. No spreadsheets reconciled at close-out.

See the ECS® ecosystem →
When you'd engage us

Three moments this service earns its place.

If any of these describe where you are, this is the right entry point.

  1. Moment 01

    Pharma or MedTech study with IMP or investigational device supply.

  2. Moment 02

    Direct-to-Participant design with home delivery under investigator oversight.

  3. Moment 03

    Cold-chain, controlled-substance or ambient biologics with excursion risk.

  4. Moment 04

    Multi-country distribution with customs, import licences and regional depots.

Related services

Often engaged together.

Direct-to-Participant & decentralised services

Home delivery, home visits, telehealth and remote eConsent, investigator-supervised via ViSA.

Learn more

Monitoring & RBQM

Quality by design across the whole study, not monitoring alone: risk assessment, on-site, remote and centralised oversight against your risk plan, corrective actions tracked on ViSA.

Learn more

Clinical Trials (interventional, DCT / hybrid)

Interventional and post-market studies run end-to-end, centralised, hybrid or fully virtual.

Learn more

Talk to the team about this service.

Tell us the study or the question, we'll come back with a scoped answer.

Discuss this serviceSee the full arc